Key facts
- This page summarizes Todd Bazemore's Form 4 filing for KALA BIO, Inc. (KALA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Mar 2025, 20:00.
Todd Bazemore - 07 Mar 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)
- Reporting relationship
- Interim Chief Executive Officer, President and Chief Operating Officer
- Issuer ticker
- KALA
- Reported as of
- 07 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Mar 2025, 20:00:08 UTC
- Prior SEC filing
- 07 Jan 2025
- Next SEC filing
- 04 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary Reumuth, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Todd Bazemore filed Form 4 for KALA BIO, Inc. (KALA) on 10 Mar 2025.
Change
- Previous filing in this sequence was filed on 07 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KALA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +45,200
- Change %
- Price
- $0.000000
- Shares after
- 45,200
- Date
- 07 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,200
- Exercise price
- $7.05
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option was granted on March 7, 2025 and vests as to 1/12th of the shares underlying the option at the end of each successive one-month period over a one-year period following February 11, 2025, subject to the Reporting Person's continued employment with the Issuer.
SEC remarks
Interim Chief Executive Officer, President and Chief Operating Officer